Lincoln Pharma Shares Gain 5 per cent On Oral Spray Launch

• Shares of Lincoln Pharmaceuticals surged nearly 5 per cent today after the company launched Ondansetron oral spray, used for treatment of nausea and vomiting caused by surgery or cancer drugs, in India. 
• The stock gained 4.71 per cent to Rs. 247.85 on BSE. 
• At NSE, shares of the company jumped 4.64 per cent to Rs. 247.80. 
• Ondansetron was earlier available as tablet, syrup and injectable in India, Lincoln Pharma said in a filing to BSE yesterday. 
• The company has "done bio-equivalent study for Ondansetron oral spray and has got the Drug Controller General of India (DCGI) permission," it added.  
• The product has been launched in the Indian market in two strengths, Lincoln Pharma said.  
• Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery.

Lincoln, pharma shares, gain 5 per cent, oral spray, launch